Are we systematically overdosing women? Revisiting standardized contrast protocols for thoracoabdominal CT scans - Takeaways - MDSpire

Are we systematically overdosing women? Revisiting standardized contrast protocols for thoracoabdominal CT scans

  • By

  • Judith Becker

  • Adrian Huber

  • Stefanie Bette

  • Anna Rubeck

  • Tim Tobias Arndt

  • Gernot Müller

  • Franka Risch

  • Luca Canalini

  • Claudia Wollny

  • Florian Schwarz

  • Christian Scheurig-Muenkler

  • Thomas Kroencke

  • Josua A. Decker

  • January 9, 2025

  • 0 min

Share

  • 1

    The study investigates whether patient sex affects iodinated contrast enhancement in thoracoabdominal CT scans using standardized protocols.

  • 2

    Women are at a higher risk of adverse reactions to iodinated contrast media compared to men, necessitating careful consideration of CM volumes.

  • 3

    The research aims to identify parameters for individualized, sex-specific CM dosing to achieve consistent contrast enhancement across genders.

  • 4

    A retrospective study design was employed, including patients with clinically indicated thoracoabdominal CT scans and specific inclusion criteria.

  • 5

    The study utilized a dual-source PCD-CT system to analyze contrast enhancement, focusing on minimizing CM use while ensuring diagnostic quality.

Original Source(s)

Are we systematically overdosing women? Revisiting standardized contrast protocols for thoracoabdominal CT scans

  • by Judith Becker, Adrian Huber, Stefanie Bette, Anna Rubeck, Tim Tobias Arndt, Gernot Müller, Franka Risch, Luca Canalini, Claudia Wollny, Florian Schwarz, Christian Scheurig-Muenkler, Thomas Kroencke, Josua A. Decker

  • January 9, 2025

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Application and prospect of artificial intelligence in diagnostic imaging of prostate cancer

Can MRI Predict Perforator Stroke Progression?

Investigators evaluate multisequence imaging for its ability to identify patients at risk for neurologic progression.